Company & Sponsor Intelligence
Odense University Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting2
Completed3
Countries1
Therapeutic footprint
migraine_headachemultiple_sclerosisneuro_oncologyout_of_scopepain_neuropathyparkinsons
Indexed studies
NCT06905587Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
neuro_oncology · DenmarkPHASE3
neuro_oncology · DenmarkPHASE3
NCT00423527Levetiracetam in Central Pain in Multiple Sclerosis(MS)
multiple_sclerosis · DenmarkPHASE4
multiple_sclerosis · DenmarkPHASE4
NCT01047488Imipramine and Pregabalin Combination in Painful Polyneuropathy
pain_neuropathy · DenmarkPHASE4
pain_neuropathy · DenmarkPHASE4
NCT02125032Transcranial Low Voltage Pulsed Electromagnetic Fields (T-PEMF) in Patients With Parkinson's Disease
parkinsons · DenmarkNA
parkinsons · DenmarkNA
NCT02047695Women With Migraine With Aura Neuroimaging Study
migraine_headache · COMPLETED
migraine_headache · COMPLETED
NCT07795047Umbilical Cord Glucose
out_of_scope · NA
out_of_scope · NA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →